Diagonal Bio develops a ground-breaking platform for fast, simple and reliable pathogen diagnostics. The company was founded at the onset of the covid-19 pandemic in 2020 with the express goal to revolutionise diagnosis of infectious diseases. Diagonal Bio is led by COB Eva Nilsagård, CEO Jack Egelund Madsen, CSO Andreas Nyberg, and CFO Per Heander. Diagonal's operations are based in Lund, Sweden and its scientific advisors include Prof. Vicent Pelechano (Karolinska Institute, Sweden), Prof. Christelle Prinz (Lund University, Sweden), Prof. Patrik Medstrand (Lund University), Prof. Tautgirdas Ruzgas (Malmö University, Sweden) and Kushagr Punyani (Spermosens AB). www.diagonalbio.com